Climb Bio, Inc.
About
11.34USD-0.62 -5.18%
Closed • Updated at 08:24 GMT+00:00Market Cap$649.33M
Volume929.1K
Beta1.97
RSI59.00
Climb Bio, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 26 2026
Climb Bio to Present on CLYM116 and Budoprutug Programs at European Renal Association (ERA) Congress 2026
May 7 2026
Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
May 5 2026
Climb Bio Hosts Budoprutug R&D Spotlight Event Highlighting Topline Subcutaneous Formulation Data, Broad B-Cell Mediated Disease Opportunity, and Upcoming Data Readouts
Apr 28 2026
Climb Bio, Inc. Announces $110.0 Million Private Placement
Apr 8 2026
Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026
Recent Videos
CLYM STOCK : RANGE BREAKOUT | CLIMB BIO STOCK
May 15, 2026
07 abril 26. Noticias acciones biotecnológicas. Resumen diario. #Español #Shorts #diario $XBI #bio
Apr 07, 2026
How to Buy Shares of Climb Bio Inc (CLYM)
Apr 05, 2026
Cómo comprar acciones de Climb Bio Inc (CLYM)
Mar 13, 2026
Community Chat
Ask AI
Try asking